Compare
SkinHealth Systems Inc. vs Angiodynamics Inc vs Tactile Systems Technology Inc vs Lemaitre Vascular Inc
| Latest fiscal year | SkinHealth Systems Inc. SKIN | Angiodynamics Inc ANGO | Tactile Systems Technology Inc TCMD | Lemaitre Vascular Inc LMAT |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2026-05-31 | 2025-12-31 | 2025-12-31 |
| Revenue | $300.79M | $320.17M | $329.52M | $249.60M |
| Revenue growth (YoY) | -10.0% | +9.5% | +12.5% | +13.5% |
| Gross margin | 65.3% | 54.6% | 75.9% | 71.5% |
| Operating margin | -6.9% | -12.5% | 8.9% | 27.2% |
| Net margin | -3.2% | -11.5% | 5.8% | 23.1% |
| Net income | -$9.52M | -$36.74M | $19.09M | $57.73M |
| EPS (Diluted) | -$0.16 | -$0.88 | $0.82 | $2.52 |
| Operating cash flow | $37.48M | $3.09M | $42.81M | $81.25M |
| Free cash flow | $37.18M | $508.0K | $40.43M | $74.47M |
| Cash & equivalents | n/a | $53.86M | $83.45M | $28.24M |
| Total assets | $499.80M | $267.16M | $273.94M | $615.69M |
| Total liabilities | $438.75M | $96.34M | $55.04M | $222.17M |
| Shareholders' equity | $61.06M | $170.82M | $218.90M | $393.52M |
| Return on year-end equity | -15.6% | -21.5% | 8.7% | 14.7% |
| Shares outstanding | 127.52M | 41.70M | 22.44M | 22.77M |
Revenue, most recent five fiscal years
| Fiscal year | SkinHealth Systems Inc. | Angiodynamics Inc | Tactile Systems Technology Inc | Lemaitre Vascular Inc |
|---|---|---|---|---|
| Latest | $300.79M Ended 2025-12-31 | $320.17M Ended 2026-05-31 | $329.52M Ended 2025-12-31 | $249.60M Ended 2025-12-31 |
| 1 year earlier | $334.29M Ended 2024-12-31 | $292.50M Ended 2025-05-31 | $292.98M Ended 2024-12-31 | $219.86M Ended 2024-12-31 |
| 2 years earlier | $397.99M Ended 2023-12-31 | $303.91M Ended 2024-05-31 | $274.42M Ended 2023-12-31 | $193.48M Ended 2023-12-31 |
| 3 years earlier | $365.88M Ended 2022-12-31 | $338.75M Ended 2023-05-31 | $246.78M Ended 2022-12-31 | $161.65M Ended 2022-12-31 |
| 4 years earlier | $260.09M Ended 2021-12-31 | $316.22M Ended 2022-05-31 | $208.06M Ended 2021-12-31 | $154.42M Ended 2021-12-31 |